Search results
Results From The WOW.Com Content Network
Patients with heart tumours usually have non-specific symptoms, such as dyspnea (in particular, shortness of breath when lying down), thoracoabdominal pain (pain in the general area around the heart), fatigue, hemoptysis, nausea and vomiting, fever, weight loss, and night sweats.
The report, which tracked cancer incidence nationwide from 1991 to 2022, found that cancer rates in women under 50 are now 82% higher than for men the same age, signaling a dramatic, steady climb ...
In fact, according to the recently released 2025 Heart Disease & Stroke Statistical Update fro the American Heart Association (AHA), 45% of all women over 20 years old have some form of ...
While men, since the later 1900s and particularly in the ’90s, have had a higher cancer incidence than women, incidence rates in women 50-64 years of age have now surpassed those in men.
Cardiovascular disease in women is an integral area of research in the ongoing studies of women's health. Cardiovascular disease (CVD) is an umbrella term for a wide range of diseases affecting the heart and blood vessels, including but not limited to, coronary artery disease, stroke, cardiomyopathy, myocardial infarctions, and aortic aneurysms.
At 40 years of age, the lifetime risk for CHD is 50% for men and 33% for women. 2000s So called "high normal blood pressure" is associated with increased risk of cardiovascular disease (high normal blood pressure is called prehypertension in medicine; it is defined as a systolic pressure of 120–139 mm Hg and/or a diastolic pressure of 80–89 ...
Cancer rates for young women are sharply rising, with women under 50 more likely to develop cancer than their male counterparts — by 82%. The rate of cancer for young women “has increased from ...
To be properly double blinded, the study required that women not be perimenopausal or have symptoms of menopause. As the average age of menopause is 51, this resulted in an older study population, with an average age of 63. Only 3.5% of the women were 50–54 years of age, the time when women usually decide whether to initiate hormonal therapy.